Busca un médico

Sebastian S. Lopez Chiriboga, M.D.

  1. Neurologist
Solicite una Consulta

Publicaciones

  1. Mangioris G, Pittock SJ, Yang B, Fryer JP, Harmsen WS, Dubey D, Flanagan EP, Lopez-Chiriboga SA, McKeon A, Mills JR, Vodopivec I, Tobin WO, Toledano M, Aksamit AJ, Zekeridou A. Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights. Ann Neurol. 2024 Oct; 96 (4):704-714 Epub 2024 July 19
    View PubMed
  2. Redenbaugh V, Fryer JP, Cacciaguerra L, Chen JJ, Greenwood TM, Gilligan M, Thakolwiboon S, Majed M, Chia NH, McKeon A, Mills JR, Lopez Chiriboga AS, Tillema JM, Yang B, Abdulrahman Y, Guo K, Vorasoot N, Valencia Sanchez C, Tajfirouz DA, Toledano M, Zekeridou A, Dubey D, Gombolay GY, Caparo-Zamalloa C, Kister I, Pittock SJ, Flanagan EP. Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid. Ann Neurol. 2024 Jul; 96 (1):34-45 Epub 2024 Apr 09
    View PubMed
  3. Middlebrooks EH, Patel V, Zhou X, Straub S, Murray JV Jr, Agarwal AK, Okromelidze L, Singh RB, Lopez Chiriboga AS, Westerhold EM, Gupta V, Sandhu SJS, Marin Collazo IV, Tao S. 7 T Lesion-Attenuated Magnetization-Prepared Gradient Echo Acquisition for Detection of Posterior Fossa Demyelinating Lesions in Multiple Sclerosis. Invest Radiol. 2024 Jul 1; 59 (7):513-518 Epub 2024 Jan 09
    View PubMed
  4. Cacciaguerra L, Abdel-Mannan O, Champsas D, Mankad K, Krecke KN, Chen JJ, Syc-Mazurek SB, Redenbaugh V, Lopez-Chiriboga AS, Valencia-Sanchez C, Hemingway C, Tillema JM, Ciccarelli O, Pittock SJ, Hacohen Y, Flanagan EP. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease. Neurology. 2024 May 28; 102 (10):e209303 Epub 2024 May 06
    View PubMed
  5. Kelly MJ, Grant E, Murchison AG, Binks S, Ramanathan S, Michael S, Handel AE, Handunnetthi L, Uy CE, Soltys JN, Dubey D, Day GS, Lopez-Chiriboga AS, Flanagan EP, Sheerin F, Irani SR. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis. JAMA Neurol. 2024 May 1; 81 (5):525-533
    View PubMed
  6. Okromelidze L, Patel V, Singh RB, Lopez Chiriboga AS, Tao S, Zhou X, Straub S, Westerhold EM, Gupta V, Agarwal AK, Murray JV, Desai A, Sandhu SJS, Marin Collazo IV, Middlebrooks EH. Central Vein Sign in Multiple Sclerosis: A Comparison Study of the Diagnostic Performance of 3T versus 7T MRI. AJNR Am J Neuroradiol. 2023 Dec 29; 45 (1):76-81
    View PubMed
  7. Elsbernd P, Cacciaguerra L, Krecke KN, Chen JJ, Gritsch D, Lopez-Chiriboga AS, Sechi E, Redenbaugh V, Morris PP, Carter JL, Wingerchuk DM, Tillema JM, Valencia-Sanchez C, Thakolwiboon S, Pittock SJ, Flanagan EP. Cerebral enhancement in MOG antibody-associated disease. J Neurol Neurosurg Psychiatry. 2023 Dec 14; 95 (1):14-18
    View PubMed
  8. Dominguez L, McKeon A, Tobin WO, Lopez-Chiriboga S. Long term outcomes in patients with anti-DPPX autoimmunity. J Neuroimmunol. 2023 Nov 15; 384:578214. Epub 2023 Sep 30.
    View PubMed
  9. Zara P, Dinoto A, Carta S, Floris V, Turilli D, Budhram A, Ferrari S, Milia S, Solla P, Mariotto S, Flanagan EP, Lopez Chiriboga AS, Sechi E. Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review. Eur J Neurol. 2023 Oct; 30 (10):3367-3376 Epub 2023 July 19
    View PubMed
  10. Cacciaguerra L, Redenbaugh V, Chen JJ, Morris P, Sechi E, Syc-Mazurek SB, Lopez-Chiriboga AS, Tillema JM, Rocca MA, Filippi M, Pittock SJ, Flanagan EP. Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology. 2023 Sep 26; 101 (13):e1376-e1381 Epub 2023 June 19
    View PubMed
  11. Fereidan-Esfahani M, Decker PA, Weigand SD, Lopez Chiriboga AS, Flanagan EP, Tillema JM, Lucchinetti CF, Eckel-Passow JE, Tobin WO. Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients. Ann Clin Transl Neurol. 2023 Sep; 10 (9):1544-1555 Epub 2023 July 13
    View PubMed
  12. Smith KM, Britton JW, Thakolwiboon S, Chia NH, Gupta P, Flanagan EP, Zekeridou A, Lopez Chiriboga AS, Valencia Sanchez C, McKeon A, Pittock SJ, Dubey D. Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies. Epilepsia. 2023 Sep; 64 (9):2385-2398 Epub 2023 July 04
    View PubMed
  13. Redenbaugh V, Chia NH, Cacciaguerra L, McCombe JA, Tillema JM, Chen JJ, Lopez Chiriboga AS, Sechi E, Hacohen Y, Pittock SJ, Flanagan EP. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Mult Scler. 2023 Jun; 29 (7):799-808 Epub 2023 May 23
    View PubMed
  14. Orozco E, Valencia-Sanchez C, Britton J, Dubey D, Flanagan EP, Lopez-Chiriboga AS, Zalewski N, Zekeridou A, Pittock SJ, McKeon A. Autoimmune Encephalitis Criteria in Clinical Practice. Neurol Clin Pract. 2023 Jun; 13(3):e200151. Epub 2023 Apr 25.
    View PubMed
  15. Dinoto A, Zara P, Mariotto S, Ferrari S, Flanagan EP, Budhram A, Orellana D, Turilli D, Solla P, Day GS, Sechi E, Lopez-Chiriboga AS. Autoimmune encephalitis misdiagnosis and mimics. J Neuroimmunol. 2023 May 15; 378:578071 Epub 2023 Mar 16
    View PubMed
  16. Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 Mar 28; 100 (13):e1418-e1432 Epub 2023 Jan 23
    View PubMed
  17. Valencia-Sanchez C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V, Montalvo M, Elsbernd PM, Tillema JM, Lopez-Chiriboga S, Budhram A, Sechi E, Kunchok A, Dubey D, Pittock SJ, Lucchinetti CF, Flanagan EP. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Ann Neurol. 2023 Feb; 93 (2):297-302 Epub 2022 Dec 02
    View PubMed
  18. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80 (1):30-39
    View PubMed
  19. Lopez Chiriboga AS. Teaching Neuro Images: Prominent spinal cord atrophy and white matter changes in adult polyglucosan body disease. Neurology. 2023; 100 (16):S152-3
  20. Lopez Chiriboga AS, Matsumoto J, Sorenson E, Klein CJ, McKeon A. Teaching Video NeuroImages: Acquired focal neuromyotonia in LGI-1 autoimmunity. Neurology. 2023; 100 (16):S98-9
  21. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 Jan 1; 80(1):30-39. Epub 1900 Jan 01.
    View PubMed
  22. Hinson SR, Honorat JA, Grund EM, Clarkson BD, Miske R, Scharf M, Zivelonghi C, Al-Lozi MT, Bucelli RC, Budhram A, Cho T, Choi E, Grell J, Lopez-Chiriboga AS, Levin M, Merati M, Montalvo M, Pittock SJ, Wilson MR, Howe CL, McKeon A. Septin-5 and -7-IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics. Ann Neurol. 2022 Dec; 92 (6):1090-1101 Epub 2022 Aug 27
    View PubMed
  23. Lazar EB, Porter AL, Prusinski CC, Dunham SR, Lopez-Chiriboga AS, Hammami MB, Dubey D, Day GS. Improving Early Recognition of Creutzfeldt-Jakob Disease Mimics. Neurol Clin Pract. 2022 Dec; 12 (6):406-413
    View PubMed
  24. Syc-Mazurek SB, Chen JJ, Morris P, Sechi E, Mandrekar J, Tillema JM, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski N, Cacciaguerra L, Buciuc M, Krecke KN, Messina SA, Bhatti MT, Pittock SJ, Flanagan EP. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated Disease. Neurology. 2022 Oct 31; 99 (18):795-799
    View PubMed
  25. Chen B, Lundstrom BN, Crepeau AZ, Dacpano L, Lopez-Chiriboga AS, Tatum WO, Freund B, Feyissa AM. Brain responsive neurostimulation device safety and effectiveness in patients with drug-resistant autoimmune-associated epilepsy. Epilepsy Res. 2022 Aug; 184:106974 Epub 2022 July 01
    View PubMed
  26. McKeon-Makki I, McKeon A, Yang B, Pittock SJ, Lopez-Chiriboga S, Komorowski L, Miske R, Zekeridou A. Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients. J Neuroimmunol. 2022 Jun 15; 367:577861. Epub 2022 Apr 04.
    View PubMed
  27. Garrido Sanabria ER, Zahid A, Britton J, Kraus GJ, Lopez-Chiriboga AS, Zekeridou A, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Dubey D. CASPR2-IgG-associated autoimmune seizures. Epilepsia. 2022 Mar; 63 (3):709-722 Epub 2022 Jan 15
    View PubMed
  28. Rodriguez A, Klein CJ, Sechi E, Alden E, Basso MR, Pudumjee S, Pittock SJ, McKeon A, Britton JW, Lopez-Chiriboga AS, Zekeridou A, Zalewski NL, Boeve BF, Day GS, Gadoth A, Burkholder D, Toledano M, Dubey D, Flanagan EP. LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry. 2022 Mar; 93 (3):309-315 Epub 2021 Nov 25
    View PubMed
  29. Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, Lopez-Chiriboga AS, Pittock SJ, Flanagan EP. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management. Front Neurol. 2022; 13:885218. Epub 2022 Jun 17.
    View PubMed
  30. Mustafa R, Passe TJ, Lopez-Chiriboga AS, Weinshenker BG, Krecke KN, Zalewski NL, Diehn FE, Sechi E, Mandrekar J, Kaufmann TJ, Morris PP, Pittock SJ, Toledano M, Lanzino G, Aksamit AJ, Kumar N, Lucchinetti CF, Flanagan EP. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions. Neurol Clin Pract. 2021 Oct; 11 (5):e601-e611
    View PubMed
  31. Redenbaugh V, Montalvo M, Sechi E, Buciuc M, Fryer JP, McKeon A, Lennon VA, Mills JR, Weinshenker BG, Wingerchuk DM, Chen JJ, Tariq Bhatti M, Lopez Chiriboga AS, Pittock SJ, Flanagan EP. Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin. 2021 Oct; 7 (4):20552173211052656 Epub 2021 Nov 26
    View PubMed
  32. Zara P, Floris V, Flanagan EP, Lopez-Chiriboga AS, Weinshenker BG, Solla P, Sechi E. Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI. Mult Scler J Exp Transl Clin. 2021 Oct; 7 (4):20552173211048761 Epub 2021 Nov 19
    View PubMed
  33. Sechi E, Krecke KN, Messina SA, Buciuc M, Pittock SJ, Chen JJ, Weinshenker BG, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski NL, Tillema JM, Kunchok A, Monaco S, Morris PP, Fryer JP, Nguyen A, Greenwood T, Syc-Mazurek SB, Keegan BM, Flanagan EP. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders. Neurology. 2021 Sep 14; 97 (11):e1097-e1109 Epub 2021 July 14
    View PubMed
  34. Chen B, Lopez Chiriboga AS, Sirven JI, Feyissa AM. Autoimmune Encephalitis-Related Seizures and Epilepsy: Diagnostic and Therapeutic Approaches. Mayo Clin Proc. 2021 Aug; 96 (8):2029-2039
    View PubMed
  35. Sechi E, Buciuc M, Pittock SJ, Chen JJ, Fryer JP, Jenkins SM, Budhram A, Weinshenker BG, Lopez-Chiriboga AS, Tillema JM, McKeon A, Mills JR, Tobin WO, Flanagan EP. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing. JAMA Neurol. 2021 Jun 1; 78 (6):741-746
    View PubMed
  36. Bohm P, Eggenberger ER, Dubey D, Kim HW, Lopez Chiriboga AS. Teaching Video NeuroImages: Periodic Alternating Nystagmus in Paraneoplastic KLHL11 Rhomboencephalitis. Neurology. 2021 May 25; 96(21):e2668-e2669. Epub 2021 Feb 15.
    View PubMed
  37. Day GS, Yarbrough MY, Kortvelyessy P, Pruss H, Bucelli RC, Fritzler MJ, Mason W, Tang-Wai DF, Steriade C, Hebert J, Henson RL, Herries EM, Ladenson JH, Lopez-Chiriboga AS, Graff-Radford NR, Morris JC, Fagan A. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis. Neurology. 2021 May 18; 96 (20):e2546-e2557 Epub 2021 Apr 01
    View PubMed
  38. Day GS, Gordon BA, Bucelli RC, Perrin RJ, Lopez-Chiriboga AS, Ances BM. Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient. J Neuroimmunol. 2021 Mar 15; 352:577474 Epub 2021 Jan 07
    View PubMed
  39. Sechi E, Krecke KN, Pittock SJ, Dubey D, Lopez-Chiriboga AS, Kunchok A, Weinshenker BG, Zalewski NL, Flanagan EP. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler. 2021 Feb; 27 (2):303-308 Epub 2020 Feb 27
    View PubMed
  40. Lopez Chiriboga S, Flanagan EP. Myelitis and Other Autoimmune Myelopathies. Continuum (Minneap Minn). 2021 Feb 01; 27(1):62-92.
    View PubMed
  41. Feyissa AM, Mohamed AS, Tatum WO, Campbell AS, Lopez-Chiriboga AS. Brain-responsive neurostimulation in adult-onset rasmussen's encephalitis. Epilepsy Behav Rep. 2021; 15:100445. Epub 2021 Mar 29.
    View PubMed
  42. Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, Dubey D, Flanagan EP, Lopez-Chiriboga S, Trenerry MR, Zalewski NL, Zekeridou A, McKeon A. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021; 3 (2):fcaa233 Epub 2021 Jan 05
    View PubMed
  43. Sechi E, Buciuc M, Flanagan EP, Pittock SJ, Banks SA, Lopez-Chiriboga AS, Bhatti MT, Chen JJ. Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder. Mult Scler Relat Disord 2021 Jan; 47:102638 Epub 2020 Nov 23
    View PubMed
  44. Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, Lopez-Chiriboga AS, Nguyen A, Greenwood TM, Lucchinetti CF, Zalewski NL, Messina SA, Flanagan EP. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. 2020 Dec 28 [Epub ahead of print]
    View PubMed
  45. Lopez-Chiriboga AS, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, Flanagan EP. Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder. JAMA Neurol. 2020 Dec 1; 77 (12):1575-1577
    View PubMed
  46. Buciuc M, Sechi E, Flanagan EP, Lopez-Chiriboga AS. Unfavorable outcome in highly relapsing MOGAD encephalitis. J Neurol Sci 2020 Nov 15; 418:117088 Epub 2020 Aug 10
    View PubMed
  47. Sechi E, Markovic SN, McKeon A, Dubey D, Liewluck T, Lennon VA, Lopez-Chiriboga AS, Klein CJ, Mauermann M, Pittock SJ, Flanagan EP, Zekeridou A. Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes. Neurology. 2020 Oct 27; 95 (17):e2442-e2452 Epub 2020 Aug 13
    View PubMed
  48. Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, Gornall M, Cicconi S, Brandt A, Berek K, Berger T, Jelcic I, Gombolay G, Oliveira LM, Callegaro D, Kaneko K, Misu T, Capobianco M, Gibbons E, Karthikeayan V, Brochet B, Audoin B, Mathey G, Laplaud D, Thouvenot E, Cohen M, Tourbah A, Maillart E, Ciron J, Deschamps R, Biotti D, Rostasy K, Neuteboom R, Hemingway C, Forsyth R, Matiello M, Webb S, Hunt D, Murray K, Hacohen Y, Lim M, Leite MI, Palace J, Solomon T, Lutterotti A, Fujihara K, Nakashima I, Bennett JL, Pandit L, Chitnis T, Weinshenker BG, Wildemann B, Sato DK, Kim SH, Huda S, Kim HJ, Reindl M, Levy M, Jarius S, Tenembaum S, Paul F, Pittock S, Marignier R, Jacob A. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients. Mult Scler Relat Disord. 2020 Sep; 44:102251 Epub 2020 June 02
    View PubMed
  49. Budhram A, Sechi E, Nguyen A, Lopez-Chiriboga AS, Flanagan EP. FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis With Seizures (FLAMES): Is immunotherapy always needed to put out the fire? Mult Scler Relat Disord 2020 Sep; 44:102283 Epub 2020 June 11
    View PubMed
  50. Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 Jul 14; 95 (2):e111-e120 Epub 2020 June 17
    View PubMed
  51. Hoftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, Joldic D, Pittock SJ, Tillema JM, Gorman M, Lassmann H, Lucchinetti CF. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020 May; 139 (5):875-892 Epub 2020 Feb 11
    View PubMed
  52. Kim HW, Lamb C, Jamali S, Lopez Chiriboga AS. Mystery Case: Anti-NMDAR encephalitis with overlapping demyelinating syndrome. Neurology. 2020 Apr 28; 94 (17):e1866-e1869 Epub 2020 Mar 31
    View PubMed
  53. Lopez-Chiriboga AS, Van Stavern G, Flanagan EP, Pittock SJ, Fryer J, Bhatti MT, Chen JJ. Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis. Neuroophthalmology. 2020 Feb; 44 (1):1-4 Epub 2019 May 28
    View PubMed
  54. Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Lopez Chiriboga SA, Devine M, Cerhan JH, Dunlay K, Sagen J, Ramberger M, Waters P, Irani SR, Pittock SJ. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy. Ann Neurol. 2020 Feb; 87 (2):313-323 Epub 2019 Dec 14
    View PubMed
  55. Kunchok A, Krecke KN, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Chen JJ, Weinshenker BG, Pittock SJ. Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)? Neurology. 2020 Jan 14; 94 (2):85-88 Epub 2019 Dec 11
    View PubMed
  56. Turnbull MT, Siegel JL, Becker TL, Stephens AJ, Lopez-Chiriboga AS, Freeman WD. Early Bortezomib Therapy for Refractory Anti-NMDA Receptor Encephalitis. Front Neurol. 2020; 11:188 Epub 2020 Mar 27
    View PubMed
  57. Lopez-Chiriboga S, Pittock SJ, Weinshenker BG, Chen JJ, Flanagan E. Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS. Mult Scler Relat Disord 2019 Oct; 35:34-35 Epub 2019 June 29
    View PubMed
  58. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, Lennon VA, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology. 2019 Sep 3; 93 (10):e954-e963 Epub 2019 Aug 01
    View PubMed
  59. Sechi E, Shosha E, Williams JP, Pittock SJ, Weinshenker BG, Keegan BM, Zalewski NL, Lopez-Chiriboga AS, Jitprapaikulsan J, Flanagan EP. Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology. Neurology. 2019 Jul 23; 93 (4):e414-e420 Epub 2019 June 24
    View PubMed
  60. Lopez Chiriboga AS, Pittock S. Episodic ataxia in CASPR2 autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2019 Mar; 6 (2):e536 Epub 2018 Dec 24
    View PubMed
  61. Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 2019 Mar 1; 76 (3):301-309
    View PubMed
  62. McKay JH, Dimberg EL, Lopez Chiriboga AS. A systematic review of Gamma-aminobutyric Acid Receptor Type B autoimmunity. Neurol Neurochir Pol. 2019; 53 (1):1-7 Epub 2019 Jan 08
    View PubMed
  63. Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018 Nov; 195:8-15 Epub 2018 July 26
    View PubMed
  64. López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurol. 2018 Nov 01; 75(11):1355-1363.
    View PubMed
  65. Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e497. Epub 2018 Aug 20.
    View PubMed
  66. Lopez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018 Sep; 84 (3):473-480
    View PubMed
  67. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A. Autoimmune septin-5 cerebellar ataxia. Neurol Neuroimmunol Neuroinflamm. 2018 Sep; 5 (5):e474 Epub 2018 July 09
    View PubMed
  68. Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ. Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis. JAMA Neurol. 2018 Jul 1; 75 (7):892-895
    View PubMed
  69. Lopez-Chiriboga AS, Flanagan EP. Diagnostic and Therapeutic Approach to Autoimmune Neurologic Disorders. Semin Neurol. 2018 Jun; 38 (3):392-402 Epub 2018 July 16
    View PubMed
  70. Lopez Chiriboga AS, Matsumoto J, Sorenson E, Klein CJ, McKeon A. Teaching Video NeuroImages: Acquired focal neuromyotonia in LGI-1 autoimmunity. Neurology. 2018 May 1; 90 (18):e1636-e1637
    View PubMed
  71. Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A. Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2018 Mar; 5 (2):e438 Epub 2018 Jan 23
    View PubMed
  72. Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018 Jan; 83 (1):166-177
    View PubMed
  73. Lopez-Chiriboga AS, Yoon JW, Siegel JL, Harriott AM, Pirris S, Eidelman BH, Freeman WD. Granulomatous Angiitis of the Central Nervous System Associated with Hodgkin's Lymphoma: Case Report and Literature Review. J Stroke Cerebrovasc Dis. 2018 Jan; 27 (1):e5-e8 Epub 2017 Sept 21
    View PubMed
  74. Lamb CJ, Lopez Chiriboga AS, Sotello Aviles DA, Mendez JC, Robinson MT. Clinical Reasoning: A 46-year-old man with persistent hiccups, cognitive dysfunction, and imbalance. Neurology. 2017 Oct 17; 89 (16):e193-e196
    View PubMed
  75. Clifton W, Akinduro OO, Lopez-Chiriboga S, Whitaker DA, Reimer R. Infection or Glioma? The False Dilemma of Primary Central Nervous System Histiocytic Sarcoma. World Neurosurg. 2017 Oct; 106:1053.e1-1053.e5 Epub 2017 July 12
    View PubMed
  76. Lopez-Chiriboga AS, Clardy SL. Emerging Subspecialties in Neurology: Autoimmune neurology. Neurology. 2017 Sep 12; 89 (11):e129-e133 Epub 2017 Sept 11
    View PubMed
  77. Lopez Chiriboga AS, Cheshire WP Jr. Trigeminal Neuralgia Following Lightning Injury. J Oral Facial Pain Headache. 2017 Fall; 31 (4):e7-e9
    View PubMed
  78. Lopez Chiriboga AS . MELAS (“Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes”) e-Pearl Neurology - R&F section. 2017.
  79. Feyissa AM, Lopez Chiriboga AS, Britton JW. Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4 (4):e353 Epub 2017 May 10
    View PubMed
  80. Lopez Chiriboga AS. Teaching NeuroImages: Prominent spinal cord atrophy and white matter changes in adult polyglucosan body disease. Neurology. 2017 May 16; 88 (20):e194-e195
    View PubMed
  81. Lopez Chiriboga AS, Siegel JL, Tatum WO, Shih JJ, Flanagan EP. Striking basal ganglia imaging abnormalities in LGI1 ab faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4 (3):e336 Epub 2017 Mar 14
    View PubMed
  82. Lopez Chiriboga AS, Konno T, van Gerpen JA. Personality Changes, Executive Dysfunction, and Motor and Memory Impairment. JAMA Neurol. 2017 Feb 1; 74 (2):245-246
    View PubMed
  83. Lopez-Chiriboga AS, Huang JF, Flanagan EP, Cheshire WP Jr. Paroxysmal sneezing in NMOSD: Further evidence of the localization of the human sneeze center. Neurol Neuroimmunol Neuroinflamm. 2017 Jan; 4 (1):e303 Epub 2016 Oct 28
    View PubMed
  84. Lopez Chiriboga AS, Yoon JW, Freeman WD, Odunukan OW, Cheshire WP Jr. Takotsubo cardiomyopathy in the setting of acute hydrocephalus secondary to neurocysticercosis. Clin Auton Res. 2016 Jun; 26 (3):235-41 Epub 2016 Mar 07
    View PubMed
  85. Lopez-Chiriboga AS, Komorowski L, Kumpfel T, Probst C, Hinson SR, Pittock SJ, McKeon A. Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes. Neurology. 2016 Mar 15; 86 (11):1009-13 Epub 2016 Feb 17
    View PubMed
  86. Bartel MJ, Bhalla R, Lopez Chiriboga AS, Eidelman BH, Lewis MD. Vision loss: another ERCP-related adverse event, also known as isolated bilateral lateral geniculate body infarction. Gastrointest Endosc. 2016 Feb; 83: (2)474-5; discussion 475-6.
    View PubMed
  87. Lopez Chiriboga AS, Snipelisky D, Arosemena M, Almeida N, Bhide V, Brumble L. A 72-year-old end-stage liver disease patient with lethargy Infectious Diseases in Clinical Practice. 2016; 24: (4)241-2.
PST-20313383